Rochester, Minnesota
CNS clinical trials in Rochester, MN
39 CNS studies are recruiting participants at sites in Rochester as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Rochester at a glance
- 39 studies are recruiting at a site in Rochester.
- By phase: Early Phase 1 (1), Phase 1 (1), Phase 1/2 (3), Phase 2 (3), Phase 3 (6), Phase 4 (3), No phase (14), Observational (8). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (25), industry (13), government (1).
- By research area: Epilepsy (14), Depression (10), Multiple Sclerosis (5), Parkinson's Disease (5), Migraine (3), ADHD (1), Schizophrenia (1).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Rochester
Basic details from each study's public record (the 30 most recently updated of 39). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Study site
- Mayo Clinic in Rochester
- Registry record
- NCT06748222 · updated
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Mayo Clinic
- Registry record
- NCT07227454 · updated
EEG-Guided Transcranial Magnetic Stimulation for Adults With Depression
- No phase
- Ages 22 to 60
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic
- Registry record
- NCT07862205 · updated
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- No phase
- Ages 22 to 70
- All sexes
- Sponsor
- Abbott Medical Devices
- Study site
- Mayo Clinic
- Registry record
- NCT06423430 · updated
Intravenous Ketamine for Treatment-Resistant Depression
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Rochester
- Registry record
- NCT06668571 · updated
Effect of Vagal Nerve Stimulation on Gastric Motor Functions
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Rochester
- Registry record
- NCT06038929 · updated
Ketogenic Intervention for Bipolar Depression
- No phase
- Ages 18 to 50
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Rochester
- Registry record
- NCT07121894 · updated
RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)
- Phase 4
- Ages 18 to 65
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Rochester
- Registry record
- NCT07266545 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Rochester, MN on ClinicalTrials.gov.
ADHD studies recruiting in Rochester
The Myelin Disorders Biorepository Project
- Observational
- All ages
- All sexes
- Sponsor
- Children's Hospital of Philadelphia
- Study site
- Mayo Clinic
- Registry record
- NCT03047369 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Rochester, MN on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Rochester
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Registry record
- NCT06989112 · updated
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Mayo Clinic - Rochester ( Site 0148)
- Registry record
- NCT06170788 · updated
Intraoperative Microelectrode Recordings Using MAVEN Compared to Standard Recording Apparatuses
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic
- Registry record
- NCT07868614 · updated
GBPDC: Gut-Brain in PD Consortium Master Protocol
- Observational
- Ages 21 to 80
- All sexes
- Sponsor
- Duke University
- Study site
- Mayo Clinic
- Registry record
- NCT07567794 · updated
Natural History Study of Synucleinopathies
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- NYU Langone Health
- Study site
- Mayo Clinic
- Registry record
- NCT01799915 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Rochester, MN on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Rochester
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- Phase 3
- Ages 18 to 55
- All sexes
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Study site
- Mayo Clinic
- Registry record
- NCT04047628 · updated
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- Phase 1/2
- Ages 18 to 65
- All sexes
- Sponsor
- Tr1X, Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT07477639 · updated
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
- No phase
- Ages 18 to 85
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Rochester
- Registry record
- NCT06788886 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Rochester, MN on ClinicalTrials.gov.
Epilepsy studies recruiting in Rochester
Biomarker Targeted Stimulation for Epileptiform Events
- No phase
- Ages 7 and older
- Male participants
- Sponsor
- Cadence Neuroscience
- Study site
- Mayo Clinic
- Registry record
- NCT06424977 · updated
Genetic Markers of Cardiovascular Disease in Epilepsy
- Observational
- Ages 18 to 50
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic
- Registry record
- NCT02824822 · updated
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
- Phase 1/2
- Ages 2 to 12
- All sexes
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT07531745 · updated
Optimizing Brain Stimulation Parameters
- No phase
- Ages 6 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic Rochester
- Registry record
- NCT06617845 · updated
Diagnosing Epilepsy To EffeCT Change
- No phase
- Ages 18 to 75
- All sexes
- Sponsor
- Epiminder America, Inc.
- Study site
- Mayo Clinic - Rochester
- Registry record
- NCT07110337 · updated
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
- Phase 1/2
- From 6 months, up to 17 years
- All sexes
- Sponsor
- Encoded Therapeutics
- Study site
- Mayo Clinic
- Registry record
- NCT05419492 · updated
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
- Observational
- Ages 18 to 75
- All sexes
- Sponsor
- Epiminder America, Inc.
- Study site
- Mayo Clinic - Rochester
- Registry record
- NCT07110454 · updated
Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
- Early Phase 1
- Ages 18 to 75
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Rochester
- Registry record
- NCT07012148 · updated
Subcortical Arousal in Perceptual Awareness
- No phase
- Ages 13 and older
- All sexes
- Sponsor
- Yale University
- Study site
- Mayo Clinic
- Registry record
- NCT06934356 · updated
Thalamus Seizure Detection With a Deep Brain Stimulator System
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Rochester
- Registry record
- NCT06700356 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Rochester, MN on ClinicalTrials.gov.
Migraine studies recruiting in Rochester
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Phase 4
- Ages 18 to 70
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic
- Registry record
- NCT06972056 · updated
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study sites
- Brackenridge Outpatient Research Pharmacy · Clinical Research Trials Unit · Mayo Clinic
- Registry record
- NCT04649242 · updated
Efficacy of Nerve Blocks for Episodic Migraine
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Rochester
- Registry record
- NCT05734625 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Rochester, MN on ClinicalTrials.gov.
Ask about studies near Rochester
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Minnesota
All Minnesota locations
92 studies recruiting across 13 cities.
Minneapolis
48 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections